HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.

AbstractBACKGROUND:
Besides their other roles, brain imaging and other biomarkers of Alzheimer's disease (AD) have the potential to inform a cognitively unimpaired (CU) person's likelihood of progression to mild cognitive impairment (MCI) and benefit subject selection when evaluating promising prevention therapies. We previously described that among baseline FDG-PET and MRI measures known to be preferentially affected in the preclinical and clinical stages of AD, hippocampal volume was the best predictor of incident MCI within 2 years (79%sensitivity/78%specificity), using standard automated MRI volumetric algorithmic programs, binary logistic regression, and leave-one-out procedures.
OBJECTIVE:
To improve the same prediction by using different hippocampal features and machine learning methods, cross-validated via two independent and prospective cohorts (Arizona and ADNI).
METHODS:
Patch-based sparse coding algorithms were applied to hippocampal surface features of baseline TI-MRIs from 78 CU adults who subsequently progressed to amnestic MCI in approximately 2 years ("progressors") and 80 matched adults who remained CU for at least 4 years ("nonprogressors"). Nonprogressors and progressors were matched for age, sex, education, and apolipoprotein E4 allele dose. We did not include amyloid or tau biomarkers in defining MCI.
RESULTS:
We achieved 92%prediction accuracy in the Arizona cohort, 92%prediction accuracy in the ADNI cohort, and 90%prediction accuracy when combining the two demographically distinct cohorts, as compared to 79%(Arizona) and 72%(ADNI) prediction accuracy using hippocampal volume.
CONCLUSION:
Surface multivariate morphometry and sparse coding, applied to individual MRIs, may accurately predict imminent progression to MCI even in the absence of other AD biomarkers.
AuthorsCynthia M Stonnington, Jianfeng Wu, Jie Zhang, Jie Shi, Robert J Bauer Iii, Vivek Devadas, Yi Su, Dona E C Locke, Eric M Reiman, Richard J Caselli, Kewei Chen, Yalin Wang, Alzheimer’s Disease Neuroimaging Initiative
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 81 Issue 1 Pg. 209-220 ( 2021) ISSN: 1875-8908 [Electronic] Netherlands
PMID33749642 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Alzheimer Disease (diagnostic imaging)
  • Cognitive Dysfunction (diagnostic imaging)
  • Disease Progression
  • Female
  • Hippocampus (diagnostic imaging)
  • Humans
  • Machine Learning
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuroimaging (methods)
  • Positron-Emission Tomography
  • Prognosis
  • Prospective Studies
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: